Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.
We review studies of the implementation of human papillomavirus (HPV) vaccination programmes in developed and developing countries. The review spans the period from establishment of long-term vaccine efficacy follow-up studies, operational research on issues of vaccine preparedness, and relevant predictive modelling studies during the pre-licensure phase to plans of phase IV effectiveness trials, forms of epidemiological surveillance, and further operational research in the post-licensure phase. Much of the research is already ongoing. Depending on the results of the planned immuno bridging studies among HIV-negative and HIV-positive women, further phase III and/or phase IV trials may be warranted.
Lehtinen
Matti
M
National Public Health Institute, Department of Infectious Disease Epidemiology, KTL, Oulu, Finland. Matti.Lehtinen@uta.fi
Herrero
Rolando
R
Mayaud
Philippe
P
Barnabas
Ruanne
R
Dillner
Joakim
J
Paavonen
Jorma
J
Smith
Peter G
PG
D019049:Developed Countries; D003906:Developing Countries; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000276:immunology*; D011358:Product Surveillance, Postmarketing; D012106:Research / Q000639:trends
D053918:Papillomavirus Vaccines